What is Bare-metal Coronary Stents - Global Market?
Bare-metal coronary stents are small, mesh-like tubes made of metal that are used to treat narrowed or blocked coronary arteries. These stents are inserted into the arteries during a procedure called angioplasty, which helps to restore blood flow to the heart muscle. Unlike drug-eluting stents, bare-metal stents do not have a coating of medication that helps prevent the artery from becoming blocked again. Instead, they rely on their physical structure to keep the artery open. The global market for bare-metal coronary stents is driven by the increasing prevalence of cardiovascular diseases, advancements in medical technology, and the growing demand for minimally invasive procedures. Despite the rise of drug-eluting stents, bare-metal stents remain a viable option for certain patients, particularly those who may not be suitable candidates for drug-eluting stents due to various medical reasons. The market is characterized by a competitive landscape with several key players striving to innovate and improve the efficacy and safety of these stents. As healthcare systems worldwide continue to focus on improving cardiovascular care, the demand for bare-metal coronary stents is expected to remain steady.
Stent Diameter ＜4mm, Stent Diameter ＞4mm in the Bare-metal Coronary Stents - Global Market:
In the global market for bare-metal coronary stents, the diameter of the stent plays a crucial role in determining its suitability for different patients and conditions. Stents with a diameter of less than 4mm are typically used in smaller coronary arteries. These smaller stents are essential for treating blockages in narrower vessels, which are often found in patients with smaller body sizes or specific anatomical considerations. The demand for stents with a diameter of less than 4mm is driven by the need for precision in treating complex coronary artery disease cases where larger stents may not be appropriate. On the other hand, stents with a diameter greater than 4mm are used in larger coronary arteries. These stents are designed to provide adequate support and maintain blood flow in wider vessels, which are common in patients with larger body sizes or more extensive arterial blockages. The choice between stent diameters is influenced by factors such as the size of the artery, the location of the blockage, and the patient's overall health condition. In the global market, manufacturers are continually innovating to produce stents with varying diameters to cater to the diverse needs of patients. The availability of stents in different sizes ensures that healthcare providers can select the most appropriate stent for each individual case, thereby optimizing treatment outcomes. The market for stents with diameters less than 4mm and greater than 4mm is expected to grow as the prevalence of coronary artery disease continues to rise globally. This growth is supported by advancements in stent technology, which aim to improve the performance and safety of these medical devices. As the global population ages and the incidence of cardiovascular diseases increases, the demand for both small and large diameter stents is likely to remain strong. Healthcare providers are increasingly recognizing the importance of personalized treatment approaches, which include selecting the right stent size for each patient. This trend is expected to drive further innovation and competition in the market, as manufacturers strive to develop stents that offer superior clinical outcomes and patient satisfaction. Overall, the global market for bare-metal coronary stents with varying diameters is poised for continued growth, driven by the need for effective and tailored solutions in the treatment of coronary artery disease.
ASCs, Hospitals, Cardiology Center, Others in the Bare-metal Coronary Stents - Global Market:
Bare-metal coronary stents are widely used in various healthcare settings, including ambulatory surgical centers (ASCs), hospitals, cardiology centers, and other medical facilities. In ASCs, these stents are often used for outpatient procedures, allowing patients to receive treatment and return home on the same day. The use of bare-metal stents in ASCs is driven by the growing demand for minimally invasive procedures that offer quicker recovery times and reduced healthcare costs. Hospitals, on the other hand, are major users of bare-metal coronary stents due to their comprehensive cardiac care services. In hospital settings, these stents are used in both emergency and elective procedures to treat patients with coronary artery disease. The availability of advanced medical equipment and specialized healthcare professionals in hospitals ensures that patients receive high-quality care during stent implantation procedures. Cardiology centers, which focus specifically on heart-related conditions, also utilize bare-metal coronary stents as part of their treatment offerings. These centers often have dedicated teams of cardiologists and support staff who are experienced in performing complex cardiac procedures. The use of bare-metal stents in cardiology centers is supported by ongoing research and clinical trials that aim to improve patient outcomes and refine treatment protocols. In addition to ASCs, hospitals, and cardiology centers, bare-metal coronary stents are also used in other healthcare settings, such as specialized clinics and research institutions. These facilities may focus on specific patient populations or conduct studies to evaluate the effectiveness of different stent types. The versatility of bare-metal stents makes them a valuable tool in the management of coronary artery disease across various healthcare environments. As the global burden of cardiovascular diseases continues to rise, the demand for bare-metal coronary stents in these settings is expected to increase. Healthcare providers are increasingly adopting these stents as part of their treatment strategies to improve patient outcomes and enhance the quality of care. The ongoing development of new stent technologies and techniques further supports the widespread use of bare-metal coronary stents in diverse healthcare settings.
Bare-metal Coronary Stents - Global Market Outlook:
The global market for bare-metal coronary stents was valued at approximately US$ 2,858.7 million in 2023. It is projected to grow to a revised size of US$ 3,938.7 million by 2030, reflecting a compound annual growth rate (CAGR) of 4.6% during the forecast period from 2024 to 2030. This growth is indicative of the increasing demand for effective cardiovascular treatments and the ongoing advancements in stent technology. According to our research, the broader global market for medical devices is estimated to be worth US$ 603 billion in 2023, with an anticipated growth rate of 5% CAGR over the next six years. This growth in the medical devices sector underscores the expanding healthcare needs and the continuous innovation in medical technologies. The bare-metal coronary stents market is a significant component of this larger medical devices market, driven by the need for reliable and cost-effective solutions for coronary artery disease. As healthcare systems worldwide strive to improve patient outcomes and manage the rising incidence of cardiovascular conditions, the demand for bare-metal coronary stents is expected to remain robust. The market outlook highlights the importance of these stents in the broader context of global healthcare advancements and the ongoing efforts to enhance cardiovascular care.
| Report Metric | Details |
| Report Name | Bare-metal Coronary Stents - Market |
| Forecasted market size in 2030 | US$ 3938.7 million |
| CAGR | 4.6% |
| Forecasted years | 2024 - 2030 |
| Segment by Type: |
|
| Segment by Application |
|
| By Region |
|
| By Company | Atrium Medical, Boston Scientific, Biosensors, Terumo, MicroPort, B.Braun |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
